product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
FoxC1 (D8A6) Rabbit mAb
catalog :
8758
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D8A6
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunoprecipitation
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig s10f
Assi S, Imperato M, Coleman D, Pickin A, Potluri S, Ptasinska A, et al. Subtype-specific regulatory network rewiring in acute myeloid leukemia. Nat Genet. 2019;51:151-162 pubmed publisher
  • immunohistochemistry; mouse
Wang L, Siegenthaler J, Dowell R, Yi R. Foxc1 reinforces quiescence in self-renewing hair follicle stem cells. Science. 2016;351:613-7 pubmed publisher
  • western blot; human; 1:1000; fig 1B
Ou Yang L, Xiao S, Liu P, Yi S, Zhang X, Ou Yang S, et al. Forkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma. Mol Med Rep. 2015;12:8003-9 pubmed publisher
product information
SKU :
8758S
Product-Name :
FoxC1 (D8A6) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R
Applications :
Immunoprecipitation
Product-Category :
Developmental Biology
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
75
Host :
Rabbit
Target :
FoxC1
Primary-Protein :
FOXC1
Alt-Names :
ARA,FKHL7,FOXC1,FREAC-3,FREAC3,Forkhead box protein C1,Forkhead-related protein FKHL7,Forkhead-related transcription factor 3,IGDA,IHG1,IRID1,RIEG3,forkhead box C1,forkhead, drosophila, homolog-like 7,forkhead-related activator 3,forkhead/winged helix-like transcription factor 7,myeloid factor-delta
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.